Angiotensin II via the angiotensin II type 1 receptor is reported to increase brain amyloid‐β levels by increasing amyloid precursor protein messenger RNA, β‐secretase activity, and presenilin expression,29 which is considered to be the basis for the vascular risk factors for developing AD. This evidence concerns the gene AGTR1 and Alzheimer disease.